TransCode Therapeutics Inc (RNAZ)
0.82
+0.11
(+15.98%)
USD |
NASDAQ |
May 03, 16:00
0.837
+0.02
(+2.07%)
After-Hours: 20:00
TransCode Therapeutics Total Assets (Quarterly): 5.170M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.170M |
| September 30, 2023 | 10.23M |
| June 30, 2023 | 5.882M |
| March 31, 2023 | 5.590M |
| December 31, 2022 | 7.588M |
| September 30, 2022 | 12.02M |
| June 30, 2022 | 14.16M |
| Date | Value |
|---|---|
| March 31, 2022 | 18.85M |
| December 31, 2021 | 22.94M |
| September 30, 2021 | 25.36M |
| June 30, 2021 | 1.522M |
| March 31, 2021 | 1.038M |
| December 31, 2020 | 1.055M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.038M
Minimum
Mar 2021
25.36M
Maximum
Sep 2021
10.11M
Average
7.588M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Citius Pharmaceuticals Inc | 97.40M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
| Theriva Biologics Inc | 55.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.529M |
| Shareholders Equity (Quarterly) | 1.641M |